Community viral load and newly reported HIV infections in Switzerland Matthias Egger Professor of Epidemiology & Public Health Institute of Social and.

Slides:



Advertisements
Similar presentations
Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
Advertisements

Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Estimating the number of Kentuckians living with HIV disease with unmet needs for HIV-related primary care in calendar year 2010  Reducing new HIV infections.
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Treatment as prevention (TASP) for HIV and HCV: The evidence and modelling Peter Vickerman.
TasP is not enough Stipulated that TasP is effective in reducing infectiousness of the treated person – But much more is required. TasP requires effective.
2006 Indiana HIV Incidence Richard T. Passey Indiana State Department of Health Office of Clinical Data and Research HIV Incidence Surveillance.
HIV Care Continuum, Men Who Have Sex with Men Only (MSMO) and Men Who Have Sex with Men and Women (MSMW), Georgia, 2012.
Late HIV Diagnoses, Georgia,
HIV Infection in Michigan January 1, 2012 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases.
HIV/AIDS Prevalence & Mortality Report, 2010 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
Hepatitis web study H EPATITIS W EB S TUDY Hepatitis A: Epidemiology Presentation Prepared by: David Spach, MD and Nina Kim, MD Last Updated: May 31, 2011.
Hepatitis C In Alaska’s Department of Corrections
The HIV/AIDS Epidemic © 2005 John B. Pryor Illinois State University.
Male circumcision and risk of HIV infection: Current epidemiological data Helen Weiss London School of Hygiene & Tropical Medicine, UK.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Factors associated with acute HIV infection diagnosis in MSM ANRS-Opportunity study Karen.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
HIV and STI Department - Centre for Infections Predictors of non-AIDS related death in a national cohort of HIV-diagnosed adults Meaghan Kall, Ruth Smith,
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Undetectable = Uninfectious ? Treatment as Prevention.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
HIV/AIDS in Michigan January 1, 2010 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases Bureau.
HIV/STD Epidemiology in Oklahoma HIV/STD Service Division of Prevention and Preparedness Oklahoma State Department of Health.
What do models estimate to be the impacts on HIV incidence of various percentages of people with HIV on ART ? National AIDS Trust Treatment as Prevention.
Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
ABSTRACT Introduction: HIV infection is growing relatively fast among seniors. Among the clinical implications are that older patients have less ability.
HIV Care Continuum, District 8- 2 Southwest (Albany), Georgia, 2012.
Arizona HIV/AIDS Events Per Year, Arizona Emergent HIV/AIDS Diagnoses,
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
Kevin Fenton, MD, PhD National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention August 5, 2008 Update on the US HIV/AIDS Crisis: Current Trends,
Washington D.C., USA, July 2012www.aids2012.org Equal behaviors, unequal risks: The role of partner transmission potential in racial HIV disparities.
1 st International Treatment as Prevention (TasP) Workshop Overview British Columbia Centre for Excellence in HIV/AIDS Julio Montaner MD, DSc(hon), FRCPC,
Quarterly HIV/AIDS Analysis for Michigan July 1, 2006 Michigan Department of Community Health HIV/STD & Other Bloodborne Infections Surveillance Section.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University Health Economics and Epidemiology Research Office July.
HIV Disease and Hepatitis C Virus (HCV) Co-Infection – Florida, 2011 HIV/AIDS & Hepatitis Program - Surveillance Section HIV Disease data from 1981 through.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV Care Continuum, District 10 Northeast (Athens), Georgia, 2012.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
TARGETED CAPACITY EXPANSION PROGRAM: SUBSTANCE ABUSE TREATMENT FOR RACIAL/ ETHNIC MINORITY POPULATIONS AT HIGH RISK FOR HIV/AIDS.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System RITA as part of routine national HIV surveillance: Experience.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.
Chicago Department of Public Health Richard M. Daley Mayor Bechara Choucair, MD Commissioner CDPH – STI/HIV Surveillance, Epidemiology and Research Section.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Quarterly HIV/AIDS Analysis for Michigan January 1, 2007 Michigan Department of Community Health HIV/STD & Other Bloodborne Infections Surveillance Section.
Viral load distribution 2012 among persons living with HIV and persons newly diagnosed Georgia, 2011.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System Predictors for high viraemia among the treatment naïve population.
HIV in America What’s New in 2012 Christopher Hurt, MD Clinical Assistant Professor NC AIDS Education and Training Center 2012 HIV Update.
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
Research to design community based prevention IAS Satellite – July 17, 2011 “Controlling the HIV epidemic – The promise of ARV-based prevention”
Update on epidemiology of HIV in New Zealand Dr Sue McAllister AIDS Epidemiology Group (AEG) University of Otago Dunedin HIV Women’s Seminar Auckland,
HIV/AIDS in Utah Edwin Espinel HIV Counseling & Testing, Partner Services Program Coordinator University of Utah May 2013 Utah Department of Health Bureau.
The Epidemiology of STIs in the HIV and AIDS Era
M. Ismail, D. Brawley, S. Baguley BASHH Annual Conference 2016
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
An estimated 10,706 AIDS cases diagnosed in 2006 were associated with injection drug use. Approximately 84% of AIDS cases associated with injection drug.
2018 Postgraduate Research Symposium: Exploring opportunities
Presentation transcript:

Community viral load and newly reported HIV infections in Switzerland Matthias Egger Professor of Epidemiology & Public Health Institute of Social and Preventive Medicine (ISPM) University of Bern CH-3012 Bern, Switzerland IAS Satellite, Rome, 17 July 2011

Introduction Individual level  Strong dose-response relation between viral load (VL) and HIV transmission in heterosexual discordant couples in Rakai, Uganda. 1 Population level  Median VL associated with HIV incidence in injecting drug users (IDU) in Vancouver, Canada. 2  Total community VL (CVL), based on most recent value, associated with new HIV-infections in San Francisco, USA Quinn et al. N Engl J Med 2000; 2. Wood et al. BMJ 2009; 3. Das et al. PLoS One

Swiss HIV Cohort Study  Nation-wide study of HIV-infected adults  >17,000 patients enrolled since 1988, 30% women  ~70% of all patients with advanced diseases enrolled, ~50% of all HIV-infected patients enrolled 3

Swiss HIV Cohort Study  Nation-wide study of HIV-infected adults  >17,000 patients enrolled since 1988, 30% women  ~70% of all patients with advanced diseases enrolled, ~50% of all HIV-infected patients enrolled  Main transmission groups represented 4

Swiss HIV Cohort Study  Nation-wide study of HIV-infected adults  >17,000 patients enrolled since 1988, 30% women  ~70% of all patients with advanced diseases enrolled, ~50% of all HIV-infected patients enrolled  Main transmission groups represented  85% on treatment in

Methods 1. HIV transmission potential in SHCS calculated using three approaches:  Total community VL based on all VL values  Infectivity based on a saturation curve. 1  Linear association between VL and infectivity Poisson model for association between number of new HIV diagnoses (national surveillance data from Swiss Federal Office of Public Health, SFOPH) and CVL in the year before 1. Fraser C, et al. Proc Natl Acad Sci USA Wilson DP, et al. Lancet 2008; 6

Imputation of VL Taffé and May. Stat Med HET – heterosexuals, MSM – men who have sex with men; IDU – injection drug users 7

Viral load in the SHCS 8 HIV-RNA New HIV infections (FOPH) <500 copies >500 copies

Predictions from Poisson model by transmission group (CVL) HET – heterosexual contacs, MSM – men who have sex with men; IDU – injection drug users 9

Strengths and limitations Strengths  Inclusion of annual VL back to time of HIV infection  Examination of CVL and HIV diagnoses in different risk groups  Comparison of different measures of HIV transmission potential Limitations  SHCS includes only ~50% of HIV+ persons  Increased transmission potential at very high VL in acute HIV infection ignored  Transmission between risk groups ignored 10

Conclusions  First national level study to show association between CVL and new HIV diagnoses  CVL in the SHCS is a simple measure to estimate the transmission potential and predict new diagnoses, particularly in MSM and IDU  In Switzerland people infected through HET are a more heterogeneous group than MSM and IDUs, which may explain the less accurate predictions in these groups  Further research, including pilot studies, are needed to better understand the feasibility and likely population effects of TasP in Switzerland 11

Acknowledgments  F. Schöni-Affolter  N Low, ISPM Bern  C Althaus, ISPM Bern  O Keiser, ISPM Bern  M Gebhardt, SFOPH  J Ambrosioni, HUG, GE  B Hirschel, HUG, GE  P Vernazza, SG  HJ Furrer, Bern  D Vuichard, Basel  R Weber, Zürich 12